Update on recognition and management of patients with acquired or inherited hypercoagulability.
As many as 20% of individuals who develop venous thromboembolism (VTE) in an outpatient setting may have a mutation in factor V (factor V Leiden) or the prothrombin gene. Through testing for the inherited and acquired conditions for VTE, the clinician can develop strategies to prevent recurrences.
Alving
B
B
Hematology/Medical Oncology Section, Washington Hospital Center, Washington, D.C. 20010, USA.
D016736:Antiphospholipid Syndrome / Q000175:diagnosis / Q000235:genetics; D001778:Blood Coagulation Disorders / Q000175:diagnosis / Q000235:genetics*; D005165:Factor V / Q000235:genetics; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation; D011516:Prothrombin / Q000235:genetics; D013924:Thrombophlebitis / Q000097:blood / Q000235:genetics; D013927:Thrombosis / Q000097:blood / Q000235:genetics*
C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin